1. Home
  2. MRAM vs SLGL Comparison

MRAM vs SLGL Comparison

Compare MRAM & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Everspin Technologies Inc.

MRAM

Everspin Technologies Inc.

HOLD

Current Price

$9.41

Market Cap

258.7M

Sector

Technology

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$76.22

Market Cap

247.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRAM
SLGL
Founded
2008
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
258.7M
247.1M
IPO Year
2016
2016

Fundamental Metrics

Financial Performance
Metric
MRAM
SLGL
Price
$9.41
$76.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$14.00
$110.00
AVG Volume (30 Days)
433.4K
10.5K
Earning Date
03-04-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$49,417,000.00
N/A
Revenue This Year
$10.87
$122.71
Revenue Next Year
$8.33
N/A
P/E Ratio
N/A
N/A
Revenue Growth
37.51
N/A
52 Week Low
$4.34
$0.40
52 Week High
$17.24
$97.97

Technical Indicators

Market Signals
Indicator
MRAM
SLGL
Relative Strength Index (RSI) 42.11 53.95
Support Level $8.42 $32.56
Resistance Level $9.74 $96.99
Average True Range (ATR) 0.58 11.27
MACD 0.00 -1.81
Stochastic Oscillator 28.25 51.89

Price Performance

Historical Comparison
MRAM
SLGL

About MRAM Everspin Technologies Inc.

Everspin Technologies Inc is a provider of Magnetoresistive Random Access Memory (MRAM) products. Its portfolio of MRAM technologies, including Toggle MRAM and Spin-transfer Torque MRAM (STT-MRAM), delivers superior performance, persistence, and reliability in non-volatile memories that transform how mission-critical data is protected against power loss. The company derives revenue from the sale of MRAM-based products in discrete unit form, licenses of and royalties on MRAM and magnetic sensor technology, the sale of backend foundry services, and design services to third parties. It recognizes revenue in three primary geographic regions; North America; Europe, the Middle East, and Africa (EMEA) and Asia-Pacific (APAC).

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: